Cargando…
Gemcitabine induced cardiomyopathy: a case of multiple hit cardiotoxicity
Gemcitabine is a commonly used antineoplastic agent used to treat a variety of cancers with rarely reported cardiac side effects. We describe a case of a 67‐year‐old woman with follicular lymphoma who experienced a rarely reported side effect of gemcitabine: cardiomyopathy. This case highlights a mu...
Autores principales: | Mohebali, Donya, Matos, Jason, Chang, James Ducksoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292629/ https://www.ncbi.nlm.nih.gov/pubmed/28217315 http://dx.doi.org/10.1002/ehf2.12113 |
Ejemplares similares
-
Gemcitabine-Induced Cardiotoxicity in Patients Receiving Adjuvant Chemotherapy for Pancreatic Cancer: A Case Series
por: Alam, Salma, et al.
Publicado: (2018) -
Gemcitabine-induced cardiomyopathy: a case report and review of the literature
por: Khan, Muhammad F, et al.
Publicado: (2014) -
Hypertrophic cardiomyopathy in a lupus patient: a case of hydroxychloroquine cardiotoxicity
por: Chang, Amanda, et al.
Publicado: (2019) -
Partially reversible bortezomib-induced cardiotoxicity: an unusual cause of acute cardiomyopathy
por: Meseeha, Marcelle G., et al.
Publicado: (2015) -
A Case of Trastuzumab-Associated Cardiomyopathy Presenting as an Acute Coronary Syndrome: Acute Trastuzumab Cardiotoxicity
por: Hidalgo, Sylvana, et al.
Publicado: (2013)